FDA Approves Test of Combined Stem Cell and Gene Therapy for ALS
Regenerative medicine investigators at the Cedars-Sinai Medical Center have received U.S. Food and Drug Administration (FDA) approval to test a novel combination stem cell-gene therapy they’ve developed to stall amyotrophic lateral sclerosis (ALS) progression. Enrollment in the trial is expected to commence soon. Also known as Lou Gehrig’s disease, ALS is…